Antipsychotic-induced alterations in D2 dopamine receptor interacting proteins within the cortex

Nadine Kabbani, Robert Levenson

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Current antipsychotic treatment involves the regulation of D2 dopamine receptor activity in the brain. Here, we examined the effects of chronic haloperidol and clozapine on cortical D2 dopamine receptors and six different dopamine receptor interacting proteins. Using comparative immunoblot analysis, we found that treatment with either haloperidol or clozapine increased D2 dopamine receptors, calcium activator protein for secretion, protein 4.1N, and neuronal calcium sensor-1 expression.Treatment with clozapine increased calmodulin and spinophilin expression, while treatment with haloperidol decreased expression of these two dopamine receptor interacting proteins. Neither antipsychotic drug was found to have an effect on filamin-A expression. These findings underscore a role for cortical D2 dopamine receptor in the mechanism of antipsychotic drug action, and suggest dopamine receptor interacting proteins as novel targets in antipsychotic drug development.

Original languageEnglish (US)
Pages (from-to)299-301
Number of pages3
JournalNeuroReport
Volume17
Issue number3
DOIs
StatePublished - Feb 1 2006

Fingerprint

Receptor-Interacting Protein Serine-Threonine Kinases
Dopamine D2 Receptors
Antipsychotic Agents
Clozapine
Dopamine
Dopamine Receptors
Haloperidol
Filamins
Calmodulin
Calcium
Brain
Proteins

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Cite this

@article{fdf884d194c946379bfbb1208a7cd3c2,
title = "Antipsychotic-induced alterations in D2 dopamine receptor interacting proteins within the cortex",
abstract = "Current antipsychotic treatment involves the regulation of D2 dopamine receptor activity in the brain. Here, we examined the effects of chronic haloperidol and clozapine on cortical D2 dopamine receptors and six different dopamine receptor interacting proteins. Using comparative immunoblot analysis, we found that treatment with either haloperidol or clozapine increased D2 dopamine receptors, calcium activator protein for secretion, protein 4.1N, and neuronal calcium sensor-1 expression.Treatment with clozapine increased calmodulin and spinophilin expression, while treatment with haloperidol decreased expression of these two dopamine receptor interacting proteins. Neither antipsychotic drug was found to have an effect on filamin-A expression. These findings underscore a role for cortical D2 dopamine receptor in the mechanism of antipsychotic drug action, and suggest dopamine receptor interacting proteins as novel targets in antipsychotic drug development.",
author = "Nadine Kabbani and Robert Levenson",
year = "2006",
month = "2",
day = "1",
doi = "10.1097/01.wnr.0000199460.24412.04",
language = "English (US)",
volume = "17",
pages = "299--301",
journal = "NeuroReport",
issn = "0959-4965",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

Antipsychotic-induced alterations in D2 dopamine receptor interacting proteins within the cortex. / Kabbani, Nadine; Levenson, Robert.

In: NeuroReport, Vol. 17, No. 3, 01.02.2006, p. 299-301.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Antipsychotic-induced alterations in D2 dopamine receptor interacting proteins within the cortex

AU - Kabbani, Nadine

AU - Levenson, Robert

PY - 2006/2/1

Y1 - 2006/2/1

N2 - Current antipsychotic treatment involves the regulation of D2 dopamine receptor activity in the brain. Here, we examined the effects of chronic haloperidol and clozapine on cortical D2 dopamine receptors and six different dopamine receptor interacting proteins. Using comparative immunoblot analysis, we found that treatment with either haloperidol or clozapine increased D2 dopamine receptors, calcium activator protein for secretion, protein 4.1N, and neuronal calcium sensor-1 expression.Treatment with clozapine increased calmodulin and spinophilin expression, while treatment with haloperidol decreased expression of these two dopamine receptor interacting proteins. Neither antipsychotic drug was found to have an effect on filamin-A expression. These findings underscore a role for cortical D2 dopamine receptor in the mechanism of antipsychotic drug action, and suggest dopamine receptor interacting proteins as novel targets in antipsychotic drug development.

AB - Current antipsychotic treatment involves the regulation of D2 dopamine receptor activity in the brain. Here, we examined the effects of chronic haloperidol and clozapine on cortical D2 dopamine receptors and six different dopamine receptor interacting proteins. Using comparative immunoblot analysis, we found that treatment with either haloperidol or clozapine increased D2 dopamine receptors, calcium activator protein for secretion, protein 4.1N, and neuronal calcium sensor-1 expression.Treatment with clozapine increased calmodulin and spinophilin expression, while treatment with haloperidol decreased expression of these two dopamine receptor interacting proteins. Neither antipsychotic drug was found to have an effect on filamin-A expression. These findings underscore a role for cortical D2 dopamine receptor in the mechanism of antipsychotic drug action, and suggest dopamine receptor interacting proteins as novel targets in antipsychotic drug development.

UR - http://www.scopus.com/inward/record.url?scp=33644554848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644554848&partnerID=8YFLogxK

U2 - 10.1097/01.wnr.0000199460.24412.04

DO - 10.1097/01.wnr.0000199460.24412.04

M3 - Article

VL - 17

SP - 299

EP - 301

JO - NeuroReport

JF - NeuroReport

SN - 0959-4965

IS - 3

ER -